Literature DB >> 34086008

Diffuse Lamellar Keratitis in a Patient Undergoing Collagen Corneal Cross-Linking 18 Years After Laser In Situ Keratomileusis Surgery.

Justin J Grassmeyer1, John G Goertz2, Brandon J Baartman2.   

Abstract

PURPOSE: To report a case of diffuse lamellar keratitis (DLK) after corneal collagen cross-linking in an eye with a remote history of laser in situ keratomileusis (LASIK) surgery.
METHODS: This is a case report and literature review.
RESULTS: This report describes the development of unilateral stage IV DLK in a patient who underwent bilateral corneal cross-linking for corneal ectasia 18 years after LASIK surgery. The patient was treated with high-dose topical steroids that were tapered over 1 month and multiple flap lifts. The ultimate best-corrected visual outcome was 20/60.
CONCLUSIONS: DLK is a potential sight-threatening complication of refractive surgery that can occur at any time in the postoperative period, even years after the procedure. Undergoing a subsequent corneal procedure that may disrupt or promote inflammation within the surgical flap-stromal interface, such as corneal collagen cross-linking, is a recognized risk factor for the development of DLK. This case suggests that patients with any history of LASIK surgery undergoing corneal cross-linking or other lamellar corneal surgeries may benefit from closer follow-up (eg, daily) than patients with no history of LASIK.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34086008      PMCID: PMC8178513          DOI: 10.1097/ICO.0000000000002653

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   3.152


  17 in total

1.  Late-onset diffuse lamellar keratitis following laser in situ keratomileusis.

Authors:  Albert Y Cheung; Bradley J Anderson; David G Heidemann; Chirag Gupta
Journal:  Can J Ophthalmol       Date:  2018-03-30       Impact factor: 1.882

2.  Pathophysiology and Treatment of Diffuse Lamellar Keratitis.

Authors:  Steven E Wilson; Rodrigo Carlos de Oliveira
Journal:  J Refract Surg       Date:  2020-02-01       Impact factor: 3.573

Review 3.  LASIK interface keratitis: epidemiology, diagnosis and care.

Authors:  David C Gritz
Journal:  Curr Opin Ophthalmol       Date:  2011-07       Impact factor: 3.761

4.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus.

Authors:  Gregor Wollensak; Eberhard Spoerl; Theo Seiler
Journal:  Am J Ophthalmol       Date:  2003-05       Impact factor: 5.258

5.  Complication and failure rates after corneal crosslinking.

Authors:  Tobias Koller; Michael Mrochen; Theo Seiler
Journal:  J Cataract Refract Surg       Date:  2009-08       Impact factor: 3.351

Review 6.  LASIK interface complications: etiology, management, and outcomes.

Authors:  J Bradley Randleman; Rupa D Shah
Journal:  J Refract Surg       Date:  2012-08       Impact factor: 3.573

7.  Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis.

Authors:  Farhad Hafezi; John Kanellopoulos; Rainer Wiltfang; Theo Seiler
Journal:  J Cataract Refract Surg       Date:  2007-12       Impact factor: 3.351

Review 8.  Early onset ectasia following laser in situ keratomileusus: case report and literature review.

Authors:  Sanjay N Rao; Randy J Epstein
Journal:  J Refract Surg       Date:  2002 Mar-Apr       Impact factor: 3.573

9.  Late-onset diffuse lamellar keratitis 4 years after femtosecond laser-assisted small incision lenticule extraction: a case report.

Authors:  Meiyan Li; Dong Yang; Yingjun Chen; Meng Li; Tian Han; Xingtao Zhou; Katherine Ni
Journal:  BMC Ophthalmol       Date:  2017-12-08       Impact factor: 2.209

10.  Diffuse lamellar keratitis after epi-off corneal crosslinking: An under-recognized complication?

Authors:  Diana B Mannschreck; Roy S Rubinfeld; Uri S Soiberman; Albert S Jun
Journal:  Am J Ophthalmol Case Rep       Date:  2019-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.